- FDA approves test to screen for malaria in blood donors
- FDA clears Diasorin Liaison Plex system
- Siemens offers anti-müllerian hormone assay
- FDA clears Sebia free light chain assays
- StatLab acquires Poly Scientific R&D
- Bio-Rad launches QC online learning center
- Sekisui gets EUA for Osom flu, SARS-CoV-2 test
- SpotFire R/ST panel gets 510(k) clearance, CLIA waiver
- Verichem releases microprotein reference materials
- Bayer, Thermo Fisher to develop NGS CDx assays
- De novo classification granted for ADAMTS13 activity test
- Bio-Rad gets My Green Lab certification
- Recordati Rare Diseases introduces educational website
- Verichem reference materials for creatinine assays
- Bio-Rad publishes third workbook in QC series
- Agilent, Incyte collaborate to develop CDx
- Innovative Lab Solutions welcomes VP of solutions
- FDA clears Avails Medical AST system
- Randox releases bladder cancer array
- Bruker to acquire EliTechGroup
- Roche to acquire LumiraDx’s POC technology
- FDA clears EDTA cartridges for SeptiCyte Rapid
- Binx, Cardinal Health enter into distribution agreement
- Cepheid gets CLIA waiver for Xpert Xpress MVP
- OGT expands NGS operations in the U.K.
- Copan gets third clearance for Colibrí system
- Qiagen Digital Insights launches NGS analysis for somatic cancer
- BD Biosciences releases RealBlue reagents
- StatLab launches PiSmart slide printer
- New chapter in digital pathology
- Verichem bilirubin, urine chemistry reference materials
- Machaon offers updated aHUS genetic panel
- FormaPath, UB CAT announce clinical R&D collaboration
- CLSI introduces country-based pricing model
- Horiba launches next-gen HELO hematology solution
- Thermo Fisher, Aesku sign distribution agreement
- BioMérieux acquires software company Lumed
- Sekisui, Aptitude partner to provide POC COVID test
- TechLab test detects C. difficile infection
- Fujirebio introduces pTau 217 plasma assay
- Roche launches next-generation qPCR system
- Qiagen STI assay cleared for use on NeuMoDx systems
- Flagship, Offspring partner to provide assay development services
- FormaPath launches AdiPress for lymph node dissection
- FDA clears MeMed BV test for use on whole blood
- Genomadix Cube cleared for CYP2C19 testing
- OGT, Intelliseq launch NGS reporting for myeloid malignancy panels
- Smart In Media launches grossing camera and software
- FDA approves treatment for rare blood clotting disorder
- CLSI releases jointly developed 2023 breakpoint implementation toolkit
- FDA clears BD MiniDraw capillary blood collection system
- Biocare Medical unveils IntelliPath+ staining instrument
- Tosoh G8 now connects to Sysmex XN-9000, XN-9100 systems
- Roche launches Elecsys HBeAg quant in CE markets
- FDA clears QuidelOrtho Savanna PCR platform and HSV 1+2/VZV assay
- Ad Astra QScout hematology analyzer gets 510(k) clearance
- LGC launches unmethylated, methylated ctDNA mutation mixes
- Mayo, Progentec to market biomarker tests for autoimmune diseases
- OGT, Intelliseq partner to advance clinical insight from NGS data
- Cardiac Advance now compatible with Beckman instruments
- TriVerity gets FDA breakthrough device designation
- BD launches next-gen blood draw technology
- FDA authorizes Invitae panel for common hereditary cancers
- Quest, Scipher partner to expand testing for patients with RA
- Revvity study shows value of NGS in newborn screening
- Veracyte announces IVD agreement with Illumina
- FDA approves therapy for myelodysplastic syndromes
- FoundationOne CDx approved for capivasertib plus fulvestrant
- Verichem reference materials for serum and urine testing
- FDA clears Thermo Fisher chromogranin A assay
- LGC acquires Kova International
- BioMérieux announces CE mark for Vidas TBI test
- Bio SB launches TintoStainer Plus automatic IHC stainer
- FDA clears Nova Prime Plus for microcapillary sample mode
- FDA approves Qiagen CDx for GIST
- FloBio bleeding risk Dx gets FDA breakthrough device designation
- FDA clears Aptiva Connective Tissue Disease Essential reagent
- HemoSonics Quantra awarded Innovative Technology contract
- Feasibililty study results evaluating Mainz advanced adenoma biomarkers
- MMQCI releases BCR-ABL IS linearity panel
- FDA clears PixCell HemoScreen for direct capillary sampling
- FDA approves Bosulif for pediatric patients with CML
- Pillar Biosciences launches OncoReveal Core LBx NGS kit
- Parasitology, infectious Dx company Eiger launches
- Wren Labs molecular Dx predicts patient response to PRRT
- Primera unveils Signature EVO slide and cassette printers
- FDA clears Alinity h-series hematology system
- Verichem enzyme calibration verifiers for liver function testing
- Sophia Genetics expands relationship with Gustave Roussy
- Visiopharm, Boston Cell Standards to develop IHC technology
- Illumina, Pillar Biosciences announce partnership
- New book in Foundations in Diagnostic Pathology series
- Comanche drug for preeclampsia gets fast track designation
- Stago Max Generation systems get DOD authorization to operate
- American Registry of Pathology Press digital library
- FDA clears Siemens Atellica CI analyzer
- Owen Mumford introduces Unistik venous blood collection devices
- KSL Diagnostics opens transplant immunology laboratory
- GADx reintroduces IT-Leish test for visceral leishmaniasis
- Evident Slideview DX VS-M1R digital scanner
- Verichem reference materials for electrolyte testing
- FDA clears respiratory viral panel for BD Max
- FDA clears Thermo Fisher assays for preeclampsia
- Cole-Parmer ultra-low temp freezers
- Siemens ELF test gets FDA breakthrough device designation
- OncoHost, BGN Technologies sign option agreement
- FBI approves Qiagen ForenSeq Mainstay workflow for NDIS
- Illumina launches DRAGEN 4.2
- Werfen completes acquisition of Immucor
- Verichem calibration verification reference materials
- FDA approves ARUP Labs AAV5 DetectCDx
- LGC launches Seraseq 22q11 female-matched reference material
- Bio-Rad launches second installment in QC workbook series
- Randox acquires Cellix
- General Data LaserTrack Flex cassette printer
- LGC launches Accurun MS2 internal control
- Bio-Rad launches bulk urine, CSF negative controls
- Siemens to distribute Scopio digital cell morphology platforms
- OGT partners with Applied Spectral Imaging
- Verichem offers free data reduction reports
- BD launches FacsDuet Premium system
- Safety-Spec launches gross room trays
- RMT introduces RmtHealthCheck
- Bruker launches TimsTOF Ultra mass spectrometer
- Danish National Genome Center selects Qiagen’s QCI Interpret
- FDA clears Immuno Concepts IgG Anti-nDNA test system
- Leica launches Bond ChromoPlex II Dual Detection kit
- BioMérieux launches BioFire Fireworks software
- Worthington Biochemical product catalog
- ZeptoMetrix introduces Protrol QC material
- FDA clears immunoassays to assess risk of preeclampsia
- SeraCare releases solid tumor CNV reference material
- Siemens launches Atellica Hema analyzers
- Momentum Consulting offers plan for lab optimization
- Early Lyme disease detection
- Visiopharm launches Ki-67 algorithm
- Beckman Coulter unveils DxI 9000 Access
- BD gets clearance for MRSA diagnostics AI software
- Verichem calibration verifiers for cholinesterase testing
- Trane Technologies acquires Helmer Scientific
- FDA clears Panther Fusion SARS-CoV-2, flu, RSV assay
- Labcorp gets exclusive license for Proteomedix prostate cancer test
- Quansys Biosciences bovine-specific ELISAs
- Randox introduces PSA and BNP control
- Laboratory billing services provider
- FDA clears POC instrument for fentanyl testing
- Siemens, Sysmex sign OEM agreement
- FDA clears Simplexa COVID-19, flu A/B assay
- BioGx Candida auris PCR assay adoption accelerates
- BD introduces Rhapsody HT Xpress system
- Quest unveils transplant diagnostic services
- Visby gets FDA clearance, CLIA waiver for sexual health test
- FDA clears Leica Biosystems MMR antibody panel
- Qiagen, Servier to develop CDx for acute myeloid leukemia drug
- Enzo Biochem to sell clinical lab to Labcorp
- Verichem Matrix Plus chemistry reference materials
- Verichem reference materials for triglyceride assays
- Bio-Rad, Element Biosciences to deliver RNA sequencing workflow
- Qiagen, Sophia partner to offer NGS solutions
- Verichem Enzyme ER Calibration Verifier kit
- AscencioDx COVID-19 test, molecular detector get EUA
- Globe Scientific introduces Globe/Euromex microscopes
- LGC launches BRCA1/2 reference materials
- NRichDx products for developing liquid biopsy assays
- Verichem reference materials for toxicology testing
- PerkinElmer debuts NGS workstation
- FDA expands approval of BD Onclarity HPV assay
- Flagship, Genomenon partnership
- SeraCare releases HRD reference materials
- Agilent releases on-deck thermal cycler for Bravo NGS platform
- Bio-Rad launches real-time PCR system
- BioMérieux Vidas Kube gets CE mark
- Roche launches antibody to identify PRAME protein expression
- General Data launches LaserTrack Flex
- EKF handheld hemoglobin analyzer with POC connectivity
- Santé, Vanguard Healthcare Staffing announce partnership
[typography font=”Droid Serif” size=”18″ size_format=”px”]Index by Company Name[/typography]
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
[typography font=”Droid Serif” size=”18″ size_format=”px”]Marketplace Companies “R”[/typography]
- Bosch, Randox invest €150 million in Vivalytic platform
- Randox releases bladder cancer array
- Randox acquires Cellix
- Randox acquires Cellix
- Randox introduces PSA and BNP control
- Randox Laboratories introduces PSA, BNP control
- Randox releases MRSA/MSSA PCR test on Vivalytic system
- Rapid COVID test available on Randox-Bosch Vivalytic
- Randox SARS-CoV-2 antibody control
- Reduced TAT for Vivalytic SARS-CoV-2 positive samples
- Randox multiplex controls for respiratory disease
- Reduced TAT for Vivalytic SARS-CoV-2 positive samples
- Randox whole pathogen controls for respiratory disease
- Randox unveils cytokine tests
- Randox QC for ToRCH test gets CE mark
- Randox unveils cytokine tests
- Randox ToRCH quality controls get CE mark
- Randox unveils molecular controls for SARS-CoV-2
- Randox STI assay gets CE mark
- Vivalytic test for detecting SARS-CoV-2
- Randox STI assay gets CE mark
- Randox introduces test for COVID-19
- Direct HbA1c testing in whole blood
- Randox launches assay for CVD risk assessment
- Randox RX series gains NGSP certification
- Randox unveils stroke test, controls
- Randox RX Daytona+ 510(k) cleared
- Randox teams up with Bosch, 5/18
- Randox teams up with Bosch
- Randox QC centralized platform, 7/17
- Updated interlaboratory data management program, 5/17
- FDA-cleared multianalyte control, 2/15
- White paper on QC in point-of-care testing, 11/14
- Randox FDA-cleared controls, 6/14
- Randox licenses sPLA2 CVD risk test from Aterovax, 8/13:87
- Liquid BNP control, 5/13:87
- External quality assessment Web site, 4/13:86
- Live data-management program for labs, 3/13:72
- FDA clears Rheonix Encompass MDx for STIs
- Rheonix rapid molecular COVID-19 test receives EUA
- Rheonix receives EUA for rapid molecular COVID-19 test
- Rapid Zika virus diagnostic, 6/16
- Microfluidic system for HIV testing, 5/16
- Rheonix to expand commercialization efforts, 12/15
- RUO molecular platform, 7/15
- Automated molecular diagnostics technology, 9/14
- FDA approves test to screen for malaria in blood donors
- Roche pTau217 test gets breakthrough device designation
- Roche CDx to ID patients eligible for Enhertu gets CE mark
- FDA approves test to screen for malaria in blood donors
- Roche to acquire LumiraDx’s POC technology
- Roche debuts Navify solutions at HIMSS24
- Roche, PathAI to develop AI digital pathology algorithms
- Roche launches Elecsys HBeAg quant in CE markets
- Roche to acquire LumiraDx’s POC technology
- Elecsys NfL test granted FDA breakthrough device designation
- Roche gets FDA approval for HPV test on Cobas 5800 system
- FDA clears Roche tTau/Abeta42 Alzheimer’s assays
- FDA expands approval for Ventana PD-L1 assay
- Roche, Eli Lilly to develop Elecsys Amyloid Plasma Panel for Alzheimer’s
- FDA expands approval for Ventana PD-L1 (SP263) assay
- Roche launches antibody to identify PRAME protein expression
- Roche launches antibodies to ID mutations in brain cancer
- Roche gets EUA for high-throughput monkeypox test
- Roche introduces Cobas 5800 to expand access to PCR testing in the U.S.
- FDA clears COVID-19 PCR test on Cobas 6800/8800 systems
- FDA clears Roche Alzheimer’s disease CSF assays
- FDA approves Ventana CDx to ID patients eligible for Elahere
- Roche launches antibody to identify PRAME protein expression
- Roche introduces Cobas 5800 system
- FDA clears COVID-19 PCR test on Cobas 6800/8800 systems
- Roche launches digital PCR system
- Roche CDx approved to ID patients eligible for Enhertu
- FDA clears Roche Cobas Pure for low- to mid-vol labs
- Roche receives EUA for Cobas SARS-CoV-2 Duo
- Roche COVID-19 test detects, differentiates BA.2.75
- Roche’s COVID-19 test detects, differentiates BA.2.75
- Roche launches BenchMark Ultra Plus, Ventana DP 600
- Roche amyloid plasma panel designated a breakthrough device
- Roche launches Cobas Pulse system
- Roche COVID-19 at-home test granted EUA
- Roche launches Cobas 5800 molecular Dx system in CE markets
- Roche AI-based digital pathology algorithms for breast cancer
- Roche launches three respiratory panels in CE markets
- Roche POC SARS-CoV-2 test gets EUA
- Cobas SARS-CoV-2 Test authorized for asymptomatic people
- Roche launches Elecsys Epstein-Barr virus immunoassay panel
- Roche adds high-throughput configurations to Cobas Pro
- Roche to acquire GenMark Diagnostics
- Roche launches Discovery Green HRP kit
- Roche test gets EUA for symptomatic, asymptomatic people
- Roche launches SARS-CoV-2 variant test
- Roche launches Elecsys Epstein-Barr virus immunoassay panel
- Roche launches SARS-CoV-2 variant test
- FDA approves Ventana ALK (D5F3) CDx assay with Lobrena
- Roche to acquire GenMark Diagnostics
- Roche CE-marked Cobas PIK3CA Mutation Test
- Roche launches CE-marked Cobas PIK3CA Mutation Test
- Roche receives EUA for Elecsys Anti-SARS-CoV-2 S test
- Cobas EGFR Mutation Test v2 gets expanded approval
- Roche receives EUA for Cobas SARS-CoV-2 & Influenza A/B test
- Roche HIV 1/2 qualitative test approved on Cobas 6800/8800
- Newsbytes
- Roche launches Cobas Prime Pre-analytical System
- FDA approves Ventana HER2 Dual ISH test as CDx
- Roche’s Elecsys IL-6 test receives FDA EUA
- Roche, Summit collaborate to provide personalized cancer care
- FDA approves Cobas EZH2 Mutation Test as CDx
- Roche’s Elecsys IL-6 test receives FDA EUA
- Roche’s COVID-19 antibody test receives EUA
- FDA approves Cobas HPV test for Cobas 6800/8800 systems
- EC approves venetoclax + obinutuzumab for CLL
- Roche develops serology test to detect COVID-19 antibodies
- Roche expands portfolio with adenovirus test
- Roche, Sarepta enter licensing agreement
- FDA approves Tecentriq combo for NSCLC
- Roche launches Zika test to markets accepting the CE mark
- Roche launches Cobas EBV, BKV tests
- EC approves Tecentriq-based combo therapy for NSCLC
- Newsbytes
- Roche launches Navify cancer guidelines app
- Roche launches Cobas EBV, BKV tests on 6800/8800 systems
- FDA approves Cobas Babesia
- Roche launches PD-L1 assay in CE markets as CDx for TNBC
- Roche, Bio-Techne expand partnership
- Roche launches IVD IHC test to detect ROS1 protein in cancer
- TV/MG test added to Cobas 6800/8800 menu
- Ipatasertib combo shows promising anti-tumor activity
- Roche to acquire Spark Therapeutics
- Roche launches Ventana HER2 Dual ISH DNA probe assay
- Roche launches Navify Mutation Profiler, Therapy Matcher
- Ventana PD-L1 (SP142) assay approved as CDx for TNBC
- FDA approvals for Roche oncology drugs
- Roche’s Xofluza approved for influenza treatment
- Tecentriq combo for TNBC prolongs PFS
- Roche launches IVD pan-TRK IHC assay
- Study: Kadcyla improved invasive disease-free survival
- Hemlibra for hemophilia A without FVIII inhibitors approved
- Roche announces availability of FoundationOne Liquid
- MU School of Medicine, Roche team up
- FDA approves Cobas HPV Test with SurePath
- Roche showcases new test options at ASM Microbe
- Roche to acquire Ignyta, 4/18
- CE-marked Cobas Plasma Separation Card, 4/18
- Roche, GE to develop digital diagnostics platform, 4/18
- Discovery Teal HRP chromogen detection kit, 3/18
- Roche gains CE mark for expanded use of PD-L1 assay,11/17
- FDA-approved tests for Roche instruments, 9/17
- Cobas Liat PCR system with four assays, 7/17
- FDA-cleared next-gen troponin T test, 6/17
- FDA clearance for Roche analyzer, assay, 3/17
- Fully automated fluorescent multiplex procedure, 2/17
- High-volume platforms, inventory solutions, 10/16
- Target enrichment systems, 9/16
- Chromogen for cancer research, 5/16
- H&E tissue staining solution, 2/16
- FDA-approved viral load tests, 12/15
- Whole exome sequencing solution, 11/15
- Roche to acquire Kapa Biosystems, 10/15
- Educational initiative, new platforms, 9/15
- Roche purchases tissue dissection technology, 2/15
- Roche, ARK distribution agreement, 12/14
- Roche products and acquisitions, 9/14
- Health Canada approves Roche’s HPV test, 7/14
- Streamlined workflow for HPV test, 9/13
- Intelligent lab automation solution, 9/13
- Streamlined workflow for Roche HPV test, 8/13:86
- Erlotinib tablets and EGFR mutation test, 7/13:104
- Roche, Hamilton introduce automated platform for DNA sample enrichment, 4/13:84
- Next-gen HCV test, 4/13:86